Regional
Northeastern Montana Stat Air Ambulance Cooperative
Drugs and doses75
A–C Acetaminophen, Adenosine, Albuterol, Alteplase, Amiodarone, Aspirin, Atropine, Calcium Chloride, Calcium Gluconate, Carboprost, Clopidogrel11
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1000 mg | IV | not captured | standing | pages 45, 49, 103 |
| Other | adult | 1000 mg | PO | not captured | standing | page 193 |
| Other | adult | 12.5 mg/kg | IV | not captured | standing | page 193 |
| Other | peds | 10–15 mg/kg | PO | not captured | standing | page 193 |
| Other | peds | 12.5 mg/kg | IV | not captured | standing | pages 45, 49, 103 |
| Other | peds | 15 mg/kg | IV | not captured | standing | page 103 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 6 mg | IV/IO | not captured | standing | pages 85, 109, 194 |
| SVT | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 85, 109, 194 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2.5–5 mg | NEB | not captured | standing | pages 52, 54, 55, 94, 100, 195 |
| Asthma / bronchospasm | peds | 0.3–0.5 mg/kg | NEB | not captured | standing | pages 52, 54, 55, 94, 100, 195 |
| Hyperkalemia | adult | 10–20 mg | NEB | not captured | standing | pages 52, 195 |
| Hyperkalemia | adult | 10–20 mg | NEB | not captured | standing | page 195 |
| Other | adult | 2.5–5 mg | NEB | every 20 minutes for 3 doses | standing | page 195 |
| Other | adult | 2.5–5 mg | NEB | not captured | standing | page 195 |
| Other | peds | 0.3–0.5 mg/kg | NEB | not captured | standing | pages 100, 195 |
| Other | peds | 2.5–5 mg | NEB | every 20 minutes for 3 doses if needed | standing | page 195 |
Alteplase
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 100 mg | IV | not captured | standing | pages 37, 196 |
| Other | adult | 15 mg | IV | not captured | standing | page 196 |
| Other | adult | 15 mg | IV | not captured | standing | page 196 |
| STEMI | adult | 100 mg | IV | not captured | standing | page 196 |
| Stroke | adult | 0.9 mg/kg | IV | not captured | standing | pages 41, 196 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 150 mg | IV | not captured | standing | pages 80, 198 |
| Other | adult | 150 mg | IV | not captured | standing | page 198 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | pages 87, 88, 112, 198 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | pages 87, 88, 112, 198 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 162–325 mg | PO | not captured | standing | pages 70, 75, 199 |
| Other | adult | 324 mg | not captured | not captured | standing | page 70 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | pages 81, 106, 200 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 81, 106, 200 |
| Other | adult | 1 mg | IV/IO | not captured | standing | page 87 |
| Other | adult | 1–2 mg | IV | not captured | standing | page 200 |
| Other | adult | 3–5 mg | IV | not captured | standing | page 200 |
| Other | peds | 0.02 mg/kg | IV/ET | not captured | standing | page 106 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 20 mg/kg | IV | not captured | standing | pages 64, 201, 202 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 10–20 mg/kg | IV | not captured | standing | pages 64, 201, 202 |
| Hyperkalemia | adult | 0.5–1 g | IV | not captured | standing | pages 52, 201, 202 |
| Hyperkalemia | peds | 20 mg/kg | IV | not captured | standing | pages 52, 201, 202 |
| Other | adult | 0.5–1 g | IV | not captured | standing | pages 52, 201 |
| Other | adult | 1 g | IV | not captured | standing | page 201 |
| Other | adult | 20 mg/kg | IV | not captured | standing | pages 64, 201, 202 |
| Other | peds | 20 mg/kg | IV | not captured | standing | pages 64, 201, 202 |
| Other | peds | 20 mg/kg | IV/IO | not captured | standing | page 202 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 60 mg/kg | IV | not captured | standing | page 203 |
| Hyperkalemia | adult | 1–2 g | IV | not captured | standing | pages 52, 203 |
| Hyperkalemia | adult | 1–2 g | IV | not captured | standing | pages 52, 203 |
| Hyperkalemia | peds | 60–100 mg/kg | IV/IO | not captured | standing | page 203 |
| Hyperkalemia | peds | 60–100 mg/kg | IV | not captured | standing | pages 52, 203 |
| Other | adult | 1.5–3 g | IV | not captured | standing | page 203 |
Carboprost
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 0.25 mg | IM | not captured | standing | pages 118, 119 |
Clopidogrel
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| STEMI | adult | 300 mg | PO | not captured | standing | pages 76, 204 |
D–F Dexmedetomidine, Dextrose, Diazepam, Diltiazem, Diphenhydramine, Dobutamine, Dopamine, Enoxaparin, Epinephrine, Esmolol, Etomidate, Famotidine, Fentanyl, Flumazenil, Fosphenytoin, Furosemide16
Dexmedetomidine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Procedural sedation | adult | 0.1–1 mcg/kg | not captured | not captured | standing | page 205 |
| Procedural sedation | adult | 0.5–1 mcg/kg | IV | not captured | standing | page 205 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 25 g | IV | not captured | standing | pages 52, 206, 234 |
| Hypoglycemia | adult | 10–25 g | IV | not captured | standing | pages 29, 96, 101, 104, 206 |
| Hypoglycemia | adult | 15–20 g | PO | not captured | standing | page 206 |
| Hypoglycemia | peds | 0.5–1 g/kg | IV | not captured | standing | pages 29, 96, 101, 104, 206 |
| Hypoglycemia | peds | 0.5–1 g/kg | IV | not captured | standing | pages 29, 206 |
| Hypoglycemia | peds | 0.5–1 g/kg | IV | not captured | standing | pages 29, 206 |
| Hypoglycemia | peds | 15–20 g | PO | not captured | standing | page 206 |
| Other | adult | 25 g | IV | not captured | standing | pages 47, 101 |
| Other | peds | 0.25 g/kg | IV/IO | not captured | standing | page 95 |
| Other | peds | 0.5–1 g/kg | IV/IO | not captured | standing | page 96 |
| Other | peds | 0.5–1 g/kg | IV | not captured | standing | page 104 |
| Other | peds | 25 g | IV | not captured | standing | pages 47, 101 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2–5 mg | PO | not captured | standing | page 207 |
| Other | adult | 2–10 mg | IV/IM | not captured | standing | page 20 |
| Other | adult | 5–10 mg | IV/PO | not captured | standing | page 207 |
| Other | peds | 1 mg | IV | not captured | standing | page 207 |
| Procedural sedation | adult | 0.05–0.1 mg/kg | IV | not captured | standing | page 207 |
| Procedural sedation | peds | 0.05–0.1 mg/kg | IV | not captured | standing | page 207 |
| Status epilepticus | adult | 5–10 mg | IV | not captured | standing | pages 47, 207 |
| Status epilepticus | peds | 0.2–0.5 mg/kg | IV | not captured | standing | pages 47, 207 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.25 mg/kg | IV/IO | not captured | standing | pages 80, 85, 208 |
| Other | peds | 0.25 mg/kg | IV/IO | not captured | standing | pages 80, 85, 208 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 25–50 mg | IV/IM | not captured | standing | pages 54, 94, 209 |
| Anaphylaxis | peds | 1–2 mg/kg | IV/IM | not captured | standing | pages 54, 94, 209 |
| Dystonic reaction | peds | 1–2 mg/kg | IV/IM | not captured | standing | page 209 |
| Nausea / vomiting | adult | 12.5–25 mg | IV | not captured | standing | page 19 |
| Other | adult | 10–50 mg | IV/IM | not captured | standing | page 209 |
| Other | adult | 12.5–25 mg | IV/IM | not captured | standing | page 19 |
| Other | peds | 1–2 mg/kg | IV/IO/IM | not captured | standing | page 94 |
| Other | peds | 1–2 mg/kg | IV/IM/PO | not captured | standing | page 209 |
Dobutamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiogenic shock | adult | 2–10 mcg/kg | IV | not captured | standing | pages 33, 211 |
| Other | adult | 2–10 mcg/kg | IV | not captured | standing | page 33 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 5–20 mcg/kg | IV | not captured | standing | pages 81, 212 |
| Hypotension / shock | peds | 2–20 mcg/kg | IV | not captured | standing | pages 33, 104, 212 |
| Other | peds | 2–20 mcg/kg | IV | not captured | standing | page 104 |
Enoxaparin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 1 mg/kg | SQ | not captured | standing | page 213 |
| Other | adult | 0.75 mg/kg | SQ | not captured | standing | pages 76, 213 |
| Other | adult | 1 mg/kg | SQ | every 12 hours or 1 | standing | pages 37, 213 |
| Other | adult | 30 mg | IV | not captured | standing | pages 76, 213 |
| STEMI | adult | 1 mg/kg | SQ | not captured | standing | pages 76, 213 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3–0.5 mg | IM | not captured | standing | pages 54, 94, 214, 215 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | pages 54, 94, 214, 215 |
| Asthma / bronchospasm | adult | 0.3–0.5 mg | IM/SQ | not captured | standing | pages 55, 100, 214 |
| Asthma / bronchospasm | peds | 0.01 mg/kg | IM/SQ | not captured | standing | pages 55, 100, 214 |
| Bradycardia | adult | 2–10 mcg | IV | not captured | standing | pages 81, 214 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 106, 215 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 87, 112, 114, 214, 215 |
| Cardiac arrest | adult | 2–2.5 mg | ET | not captured | standing | pages 214, 215 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 87, 112, 114, 214, 215 |
| Other | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 87, 106, 112, 114, 215 |
Esmolol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 500 mcg/kg | IV | not captured | standing | pages 30, 217 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | peds | 0.2–0.4 mg/kg | IO | not captured | standing | page 218 |
| RSI induction | adult | 0.3 mg/kg | IV | not captured | standing | page 218 |
| RSI induction | peds | 0.2–0.4 mg/kg | IV | not captured | standing | page 218 |
Famotidine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 20 mg | IV | not captured | standing | pages 54, 94 |
| Anaphylaxis | peds | 0.5 mg/kg | IV | not captured | standing | pages 54, 94 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 25–50 mcg | IV | not captured | standing | page 89 |
| Other | adult | 25 mcg | not captured | not captured | standing | page 220 |
| Mild to moderate pain | adult | 0.5–2 mcg/kg | IV | not captured | standing | page 21 |
| Mild to moderate pain | peds | 0.5–1 mcg/kg | IV | not captured | standing | page 21 |
| RSI induction | adult | 1–3 mcg/kg | IV | not captured | standing | page 172 |
Flumazenil
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.2 mg | IV | not captured | standing | page 221 |
| Other | adult | 0.2 mg | IV | not captured | standing | page 221 |
Fosphenytoin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Head injury / TBI | adult | 17–20 mg/kg | IV | not captured | standing | page 223 |
| Seizure | adult | 10–20 mg/kg | IV/IM | not captured | standing | pages 48, 223 |
| Status epilepticus | adult | 20 mg/kg | IV/IM | not captured | standing | pages 48, 101, 223 |
| Status epilepticus | peds | 1–2 mg/kg | IV/IM | not captured | standing | pages 48, 101, 223 |
Furosemide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 20–40 mg | IV | not captured | standing | pages 68, 224 |
| Other | adult | 20 mg | IV/IO | not captured | standing | page 150 |
| Other | adult | 20–40 mg | IV | not captured | standing | pages 68, 224 |
G–L Glucagon, Haloperidol, Heparin, Hydralazine, Hydrocortisone, Hydromorphone, Hydroxocobalamin, Hypertonic Saline, Ibuprofen, Insulin, Insulin Regular, Ipratropium, Ketamine, Labetalol, Levetiracetam, Lidocaine, Lorazepam17
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 3–10 mg | IV | not captured | standing | pages 64, 225 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.05 mg/kg | IV | not captured | standing | pages 64, 225 |
| Hypoglycemia | adult | 1 mg | IV/IM/SQ | not captured | standing | pages 29, 47, 225 |
| Hypoglycemia | peds | 0.5 mg | IV/IM/SQ | not captured | standing | pages 29, 47, 225 |
| Other | peds | 0.5 mg | IV/IM/SQ | not captured | standing | page 96 |
| Other | peds | 1 mg | IV/IM/SQ | not captured | standing | page 96 |
| Other | peds | 1 mg | IV/IM/SQ | not captured | standing | page 101 |
Haloperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2–10 mg | IV/IM | not captured | standing | pages 20, 227 |
| Agitation | peds | 0.025–0.075 mg/kg | IV/IM | not captured | standing | pages 20, 227 |
Heparin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 60 unit/kg | IV | not captured | standing | page 73 |
| Other | adult | 60 unit/kg | IV | not captured | standing | pages 73, 76, 78, 228 |
| Other | adult | 80 unit/kg | IV | not captured | standing | page 37 |
| STEMI | adult | 60 unit/kg | IV | not captured | standing | pages 76, 78 |
Hydralazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10–20 mg | IV/IM | not captured | standing | page 229 |
| Other | adult | 5–10 mg | IV | not captured | standing | pages 35, 229 |
| Other | adult | 5–10 mg | IV | not captured | standing | page 35 |
Hydrocortisone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 50 mg | IV | not captured | standing | pages 49, 230 |
| Sepsis | adult | 50 mg | IV | not captured | standing | pages 49, 230 |
Hydromorphone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 0.2–1 mg | IV | not captured | standing | pages 21, 231 |
| Severe pain | adult | 0.2–1 mg | IV/IM | not captured | standing | page 231 |
| Severe pain | peds | 0.015 mg/kg | IV | not captured | standing | pages 21, 231 |
| Severe pain | peds | 0.2–0.6 mg | IV | not captured | standing | pages 21, 231 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV | not captured | standing | pages 66, 232 |
| Cyanide poisoning | adult | 5 g | IV | not captured | standing | page 66 |
| Cyanide poisoning | adult | 5 g | IV/IO | not captured | standing | page 232 |
| Cyanide poisoning | peds | 70 mg/kg | IV | not captured | standing | pages 66, 232 |
| Cyanide poisoning | peds | 70 mg/kg | IV | not captured | standing | page 66 |
| Other | peds | 70 mg/kg | IV/IO | not captured | standing | page 232 |
Hypertonic Saline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 250 mL | IV | not captured | standing | pages 39, 44, 46, 137, 233 |
| Other | peds | 5 mL/kg | IV | not captured | standing | pages 39, 44, 46, 137, 233 |
Ibuprofen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 400 mg | IV | not captured | standing | page 103 |
| Fever | peds | 10 mg/kg | IV | not captured | standing | page 103 |
| Fever | peds | 400 mg | IV | not captured | standing | page 103 |
Insulin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 10 unit | IV | not captured | standing | pages 52, 234 |
| Hyperkalemia | peds | 0.1 unit/kg | IV | not captured | standing | pages 52, 234 |
| Other | adult | 0.05 unit/kg | IV | not captured | standing | pages 24, 25 |
| Other | adult | 0.1 unit/kg | IV | not captured | standing | page 234 |
| Other | adult | 0.1 unit/kg | IV | not captured | standing | page 27 |
| Other | peds | 0.05–0.1 unit/kg | IV | not captured | standing | page 234 |
Insulin Regular
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperglycemia / DKA | adult | 0.1 unit/kg | IV | not captured | standing | pages 24, 27, 234 |
| Hyperglycemia / DKA | peds | 0.05–0.1 unit/kg | IV | not captured | standing | pages 24, 27, 234 |
| Hyperkalemia | adult | 10 unit | IV | not captured | standing | pages 52, 234 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| COPD | adult | 0.5 mg | NEB | not captured | standing | page 235 |
| Other | adult | 0.5 mg | NEB | not captured | standing | page 55 |
| Other | adult | 0.5 mg | NEB | not captured | standing | pages 55, 100, 228 |
| Other | peds | 0.25 mg | NEB | not captured | standing | pages 55, 100, 228 |
| Other | peds | 0.25 mg | NEB | not captured | standing | pages 100, 235 |
| Other | peds | 0.5 mg | NEB | not captured | standing | pages 100, 235 |
| Other | peds | 4–8 puff | MDI | not captured | standing | page 235 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 1–2 mg/kg | IV | not captured | standing | page 236 |
| Agitation | adult | 4–6 mg/kg | IM | not captured | standing | page 236 |
| Mild to moderate pain | adult | 0.25–0.5 mg/kg | IV | not captured | standing | pages 21, 236 |
| Mild to moderate pain | adult | 0.25–0.5 mg/kg (max 35 mg) | IV | not captured | standing | pages 21, 236 |
| RSI induction | adult | 1–2 mg/kg | IV | not captured | standing | pages 172, 236 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 mg | IV | not captured | standing | pages 41, 44, 237 |
| Other | adult | 10–20 mg | IV | not captured | standing | pages 32, 35, 41, 44, 237 |
| Other | adult | 10–20 mg | IV | not captured | standing | pages 41, 237 |
| Other | adult | 10–20 mg | IV | not captured | standing | pages 35, 237 |
| Other | adult | 20 mg | IV | not captured | standing | page 32 |
| Other | adult | 5–40 mg | IV | not captured | standing | pages 39, 237 |
| Other | adult | 5–40 mg | IV | not captured | standing | page 237 |
Levetiracetam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Head injury / TBI | adult | 20 mg/kg | IV | not captured | standing | page 238 |
| Other | adult | 40–60 mg/kg | IV | not captured | standing | pages 48, 238 |
| Other | peds | 60 mg/kg | IV | not captured | standing | page 101 |
| Status epilepticus | adult | 1–3 g | IV | not captured | standing | pages 48, 101, 238 |
| Status epilepticus | peds | 20–60 mg/kg | IV | not captured | standing | pages 48, 101, 238 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | pages 87, 239 |
| Wide-complex tachycardia | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | pages 83, 239 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 1–4 mg | IV/IM | not captured | standing | pages 20, 240 |
| Agitation | peds | 0.05–0.1 mg/kg | IV/IM | not captured | standing | pages 20, 240 |
| Other | adult | 1–2 mg | IV | not captured | standing | page 59 |
| Other | adult | 2–4 mg | IV | not captured | standing | page 240 |
| Other | peds | 0.05 mg/kg | IV/PO | not captured | standing | page 240 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 101 |
| Other | peds | 0.25–2 mg | PO | not captured | standing | page 240 |
| Status epilepticus | adult | 4 mg | IV | not captured | standing | pages 47, 240 |
| Status epilepticus | peds | 0.1 mg/kg | IV | not captured | standing | pages 47, 240 |
M–O Magnesium Sulfate, Mannitol, Methylergonovine, Methylprednisolone, Metoclopramide, Metoprolol, Midazolam, Milrinone, Misoprostol, Morphine, Naloxone, Nicardipine, Nitroglycerin, Nitroprusside, Norepinephrine, Octreotide, Ondansetron17
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–2 g | IV | not captured | standing | pages 83, 241 |
| Other | adult | 2 g | IV | not captured | standing | pages 55, 241 |
| Other | peds | 2 g | IV | not captured | standing | pages 55, 241 |
| Other | peds | 50 mg/kg | IV | not captured | standing | page 100 |
| VF / pulseless VT | adult | 1–2 g | IV/IO | not captured | standing | pages 87, 112, 241 |
| VF / pulseless VT | peds | 50 mg/kg | IV/IO | not captured | standing | pages 87, 112, 241 |
Mannitol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Head injury / TBI | adult | 1 g/kg | IV/IO | not captured | standing | pages 39, 44, 46, 137 |
| Other | adult | 0.25–1 g/kg | IV | not captured | standing | page 242 |
| Other | peds | 0.25–1 g/kg | IV | not captured | standing | page 242 |
Methylergonovine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 0.2 mg | IM | not captured | standing | pages 118, 119 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 1–2 mg/kg | IV | not captured | standing | pages 54, 94, 243 |
| Anaphylaxis | adult | 1–2 mg/kg | not captured | not captured | standing | pages 54, 243 |
| Anaphylaxis | peds | 1–2 mg/kg | IV | not captured | standing | pages 54, 94, 243 |
| Asthma / bronchospasm | adult | 60–125 mg | IV | not captured | standing | pages 55, 100, 243 |
| Asthma / bronchospasm | adult | 60–125 mg | not captured | not captured | standing | page 243 |
| Asthma / bronchospasm | peds | 2 mg/kg | IV | not captured | standing | pages 55, 100, 243 |
Metoclopramide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 5–10 mg | IV | not captured | standing | pages 19, 244 |
| Other | adult | 5–10 mg | IV | not captured | standing | page 19 |
Metoprolol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 2.5–5 mg | IV/IO | not captured | standing | pages 80, 245 |
| Other | adult | 2.5–5 mg | IV/IO | not captured | standing | pages 80, 245 |
| Other | adult | 5 mg | IV | not captured | standing | page 32 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5–5 mg | IV/IM | not captured | standing | pages 20, 246 |
| Agitation | peds | 0.05–0.1 mg/kg | IV/IM | not captured | standing | pages 20, 246 |
| Other | adult | 2 mg | IV | not captured | standing | pages 89, 246 |
| Other | adult | 2.5–5 mg | IV/IM | not captured | standing | page 20 |
| Other | adult | 2.5–5 mg | IV | not captured | standing | pages 34, 246 |
| RSI induction | adult | 0.1 mg/kg | IV | not captured | standing | pages 172, 246 |
| RSI induction | adult | 0.2 mg/kg | IV | not captured | standing | page 246 |
| Seizure | adult | 10 mg | IM | not captured | standing | pages 47, 101, 246 |
| Seizure | peds | 0.2 mg/kg | IM | not captured | standing | pages 47, 101, 246 |
Milrinone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.125–0.25 mcg/kg | IV | not captured | standing | pages 69, 248 |
| Other | adult | 0.125–0.25 mcg/kg | IV | not captured | standing | page 69 |
Misoprostol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 800–1000 mcg | SL/PR | not captured | standing | pages 118, 119 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 2–4 mg | IV | not captured | standing | pages 71, 249 |
| Mild to moderate pain | adult | 4–10 mg | IV | not captured | standing | pages 21, 249 |
| Mild to moderate pain | peds | 0.05–1 mg/kg | IV | not captured | standing | pages 21, 249 |
| Mild to moderate pain | peds | 2–5 mg | IV | not captured | standing | pages 21, 249 |
| Severe pain | adult | 4–10 mg | IV/IM/SQ | not captured | standing | page 249 |
| Severe pain | peds | 0.05–1 mg/kg | IV/IM/SQ | not captured | standing | page 249 |
| Severe pain | peds | 2–5 mg | IV/IM/SQ | not captured | standing | page 249 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.4–2 mg | IV/IO | not captured | standing | pages 63, 64, 250 |
| Opioid overdose | adult | 0.4–2 mg | IV/IM/SQ | not captured | standing | page 250 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 63, 64, 250 |
| Opioid overdose | peds | 2 mg | IV/IO | not captured | standing | pages 64, 250 |
| Other | adult | 0.25–6.25 mg | IV | not captured | standing | page 250 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 96 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | page 250 |
| Other | peds | 2 mg | IV | not captured | standing | page 250 |
Nicardipine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 5 mg | IV | not captured | standing | page 32 |
| Other | adult | 5 mg | IV | not captured | standing | page 251 |
| Other | adult | 5 mg | IV | not captured | standing | pages 30, 32, 35, 39, 41, 44, 251 |
| Other | adult | 5 mg | IV | not captured | standing | page 39 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | pages 70, 75, 252 |
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 70 |
| Other | adult | 0.3–0.4 mg | SL | not captured | standing | page 252 |
Nitroprusside
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 0.1–0.3 mcg/kg | IV | not captured | standing | pages 69, 253 |
| Other | adult | 0.25–0.5 mcg/kg | IV | not captured | standing | page 253 |
| Other | adult | 0.25–0.5 mcg/kg | IV | not captured | standing | page 32 |
| Other | adult | 0.25–0.5 mcg/kg | IV | not captured | standing | pages 30, 32, 35, 253 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 5–25 mcg | IV | not captured | standing | pages 33, 49, 104, 254 |
| Hypotension / shock | peds | 0.1–2 mcg/kg | IV | not captured | standing | pages 33, 49, 104, 254 |
| Hypothermia | adult | 2–20 mcg | IV | not captured | standing | page 57 |
| Other | adult | 0.05–0.15 mcg/kg | IV | not captured | standing | page 254 |
| Other | adult | 5 mcg | IV | not captured | standing | pages 41, 44 |
| Other | adult | 5–25 mcg | IV | not captured | standing | page 254 |
| Other | peds | 0.1–2 mcg/kg | IV | not captured | standing | page 104 |
| Sepsis | adult | 5–25 mcg | IV | not captured | standing | page 49 |
Octreotide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 50 mcg | IV | not captured | standing | pages 50, 255 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4–8 mg | IV/IM | not captured | standing | pages 19, 71, 256 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IM | not captured | standing | pages 19, 71, 256 |
| Nausea / vomiting | peds | 4 mg | IV | not captured | standing | pages 19, 256 |
| Nausea / vomiting | peds | 4 mg | IV/IM | not captured | standing | page 256 |
| Other | adult | 4–8 mg | IV/IM/PO | not captured | standing | page 256 |
| Other | adult | 4 mg | IV | not captured | standing | page 71 |
| Other | adult | 4 mg | IV/IM | not captured | standing | page 19 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | page 19 |
| Other | peds | 2 mg | PO | not captured | standing | page 19 |
P–R Pantoprazole, Phenylephrine, Phenytoin, Potassium Chloride, Promethazine, Ranitidine, Rocuronium7
Pantoprazole
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 80 mg | IV | not captured | standing | page 50 |
| Other | adult | 80 mg | IV | not captured | standing | page 257 |
| Other | adult | 80 mg | IV | not captured | standing | page 257 |
Phenylephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiogenic shock | adult | 0.5–2 mcg/kg | IV | not captured | standing | page 258 |
| Hypotension / shock | adult | 0.5–2 mcg/kg | IV | not captured | standing | pages 33, 258, 259 |
| Other | adult | 0.5–2 mcg/kg | IV | not captured | standing | page 258 |
| Other | adult | 40–100 mcg | IV | not captured | standing | page 258 |
| Other | peds | 5–20 mcg/kg | IV | not captured | standing | page 259 |
Phenytoin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Head injury / TBI | adult | 17–20 mg/kg | IV | not captured | standing | page 260 |
| Other | adult | 20 mg/kg | IV | not captured | standing | page 260 |
| Other | peds | 15–20 mg/kg | IV | not captured | standing | page 101 |
| Seizure | adult | 15 mg/kg | IV/PO | not captured | standing | pages 260, 261 |
| Seizure | peds | 15–20 mg/kg | IV/PO | not captured | standing | pages 260, 261 |
| Status epilepticus | adult | 20 mg/kg | IV | not captured | standing | pages 48, 260 |
| Status epilepticus | peds | 120 mg/kg | IV | not captured | standing | pages 48, 260 |
Potassium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10–20 mEq | IV | not captured | standing | pages 51, 261 |
| Other | adult | 20 mEq | IV | not captured | standing | page 27 |
| Other | adult | 20–60 mEq | IV | not captured | standing | pages 261, 262 |
| Other | adult | 20–60 mEq | IV | not captured | standing | page 261 |
| Other | peds | 0.5–1 mEq/kg | IV | not captured | standing | pages 261, 262 |
Promethazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 12.5 mg | IV/IM | not captured | standing | pages 19, 262 |
| Nausea / vomiting | peds | 0.25–0.5 mg/kg | IV/IM | not captured | standing | pages 19, 262 |
| Other | peds | 0.25–0.5 mg/kg | IV | not captured | standing | page 262 |
Ranitidine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 50 mg | IV | not captured | standing | page 263 |
| Anaphylaxis | peds | 1 mg/kg | IV | not captured | standing | page 263 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | peds | 1 mg/kg | IV | not captured | standing | page 264 |
| RSI induction | adult | 0.6–1 mg/kg | IV | not captured | standing | page 264 |
| RSI induction | adult | 1–1.2 mg/kg | IV | not captured | standing | page 264 |
| RSI induction | peds | 0.6–1.2 mg/kg | IV | not captured | standing | page 264 |
S–Z Sodium Bicarbonate, Succinylcholine, Tenecteplase, Thiamine, Tranexamic Acid, Vasopressin, Vecuronium7
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1 mEq/kg | IV | not captured | standing | page 265 |
| Crush injury | adult | 50 mEq | IV | not captured | standing | pages 128, 265 |
| Other | adult | 100 mmol | IV | not captured | standing | page 27 |
| Tricyclic overdose | adult | 1–2 mEq/kg | IV | not captured | standing | pages 64, 265 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1–1.5 mg/kg | IV | not captured | standing | pages 172, 266 |
| RSI induction | peds | 1–1.5 mg/kg | IV | not captured | standing | pages 172, 266 |
Tenecteplase
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Stroke | adult | 0.25 mg/kg | IV | not captured | standing | pages 41, 267 |
Thiamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 100 mg | IV/IM | not captured | standing | pages 29, 47, 269 |
| Other | adult | 100 mg | IV | not captured | standing | page 47 |
| Other | adult | 100 mg | IV/IM | not captured | standing | page 269 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 2 g | IV | not captured | standing | page 118 |
| Other | adult | 2 g | IV | not captured | standing | pages 118, 270 |
Vasopressin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.03 unit | IV | not captured | standing | page 271 |
| Other | adult | 0.2–0.4 unit | IV | not captured | standing | pages 50, 271 |
| Other | adult | 0.2–0.4 unit | IV | not captured | standing | page 50 |
| Sepsis | adult | 0.03 unit | IV | not captured | standing | pages 49, 271 |
| Sepsis | adult | 0.03 unit | IV | not captured | standing | pages 49, 271 |
Vecuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.1–0.2 mg/kg | IV | not captured | standing | pages 172, 272 |
Cite this
Northeastern Montana Stat Air Ambulance Cooperative, United States EMS Protocol Census. 323 dose entries, effective 2026-01-01.
https://protoquiz.com/census/agencies/northeastern-montana-stat-air-ambulance-cooperative/
The census is free and not for sale. Only public agencies are named.